CN Patent

CN104058992A — 左旋米那普仑盐酸盐的晶型

Assigned to Shanghai Shyndec Pharmaceutical Co Ltd · Expires 2014-09-24 · 12y expired

What this patent protects

本发明提供了左旋米那普仑盐酸盐的晶型，其粉末X射线衍射图中，在衍射角2θ为5.94、11.90、13.60度(°)处有主要特征峰，以及该晶型的制备方法、包含该晶型的药物组合物以及该晶型在药物制备中应用。

USPTO Abstract

本发明提供了左旋米那普仑盐酸盐的晶型，其粉末X射线衍射图中，在衍射角2θ为5.94、11.90、13.60度(°)处有主要特征峰，以及该晶型的制备方法、包含该晶型的药物组合物以及该晶型在药物制备中应用。

Drugs covered by this patent

levomilnacipran-hydrochloride (LEVOMILNACIPRAN HYDROCHLORIDE)

Patent Metadata

Patent number: CN104058992A
Jurisdiction: CN
Classification: —
Expires: 2014-09-24
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Shyndec Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.